Accessibility Menu
 
RenovoRx logo

RenovoRx

(NASDAQ) RNXT

Current Price$0.90
Market Cap$39.80M
Since IPO (2021)-88%
5 YearN/A
1 Year-11%
1 Month-9%

RenovoRx Financials at a Glance

Market Cap

$39.80M

Revenue (TTM)

$1.12M

Net Income (TTM)

$11.17M

EPS (TTM)

$-0.32

P/E Ratio

-2.80

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.90

Volume

1,796

Open

$0.87

Previous Close

$0.90

Daily Range

$0.87 - $0.91

52-Week Range

$0.70 - $1.45

RNXT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RenovoRx

Industry

Biotechnology

Employees

17

CEO

Shaun R. Bagai

Headquarters

Mountain View, CA 94022, US

RNXT Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

-11%

Net Income Margin

-10%

Return on Equity

-226%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-35.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$39.80M

Shares Outstanding

45.05M

Volume

1.80K

Avg. Volume

331.39K

Financials (TTM)

Gross Profit

$796.00K

Operating Income

$12.51M

EBITDA

$12.51M

Operating Cash Flow

$10.97M

Capital Expenditure

$2.00K

Free Cash Flow

$10.97M

Cash & ST Invst.

$7.02M

Total Debt

$107.00K

RenovoRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$238.00K

+453.5%

Gross Profit

$210.00K

+388.4%

Gross Margin

88.24%

N/A

Market Cap

$39.80M

N/A

Market Cap/Employee

$3.98M

N/A

Employees

10

N/A

Net Income

$2.94M

-2.2%

EBITDA

$3.52M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$6.92M

+0.6%

Accounts Receivable

$139.00K

+223.3%

Inventory

$189.00K

N/A

Long Term Debt

$107.00K

-49.5%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.38%

N/A

Return on Invested Capital

-2.04%

N/A

Free Cash Flow

$3.02M

-23.7%

Operating Cash Flow

$3.02M

-24.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANVSAnnovis Bio, Inc.
$2.00+1.52%
ELUTElutia Inc.
$1.01-0.98%
PYPDPolyPid Ltd.
$4.44-1.33%
TVRDTvardi Therapeutics, Inc.
$3.14-0.32%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About RNXT

What is the current price of RenovoRx?

RenovoRx is trading at $0.90 per share.

What is the 52-week range for RenovoRx?

Over the past 52 weeks, RenovoRx has traded between $0.70 and $1.45.

How much debt does RenovoRx have?

As of the most recent reporting period, RenovoRx reported total debt of $212,000.

How much cash does RenovoRx have on hand?

RenovoRx reported $7.02M in cash and cash equivalents in its most recent financial results.

What is RenovoRx’s dividend yield?

RenovoRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.